Enanta Pharmaceuticals Inc (ENTA) stock
ENTANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q4 FY2026, quarter ended Sep 30, 2026Last filing: 10-K on Nov 18, 2026Score 2/302% above fair value
$8.69−1.98 (-18.56%)
Close on Nov 17, 2026Market cap $253.10MP/E –Yield –
Enanta Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Enanta Pharmaceuticals's market cap was $337.79M on Nov 11, 2026, against $301.98M a year earlier. Over the last 5 years it ranged from $109.29M to $1.51B, with a median of $337.79M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $337.79M | +0.2% |
| 2025 | Dec 31, 2025 | $337.27M | +174.3% |
| 2024 | Dec 31, 2024 | $122.98M | -37.9% |
| 2023 | Dec 29, 2023 | $198.17M | -79.5% |
| 2022 | Dec 30, 2022 | $967.20M | -36.1% |
| 2021 | Dec 31, 2021 | $1.51B | +79.0% |
| 2020 | Dec 31, 2020 | $845.24M | -30.6% |
| 2019 | Dec 31, 2019 | $1.22B | -11.4% |
| 2018 | Dec 31, 2018 | $1.37B | +22.4% |
| 2017 | Dec 29, 2017 | $1.12B | +75.9% |
| 2016 | Dec 30, 2016 | $637.71M | +3.2% |
| 2015 | Dec 31, 2015 | $618.03M | -34.6% |
| 2014 | Dec 31, 2014 | $945.53M | +93.3% |
| 2013 | Dec 31, 2013 | $489.12M | – |
See a number that looks wrong?